
Synaptica Ventures Announces Publication of Groundbreaking mRNA-Based Therapy Protocol for BRCA1-Mutated Cancers
Synaptica Ventures publishes mRNA BRCA1 therapy protocol on Protocols.io, seeks research oncologist and funding to lead groundbreaking cancer treatment study. GLENTIES, CO. DONEGAL, IRELAND, September 20, 2024 /EINPresswire.com/ -- Synaptica Ventures is …